Binding of the nucleoside transport inhibitor nitrobenzylthioinosine to Hela cells
Lauzon, G.J.; Paterson, A.R.
Molecular Pharmacology 13(5): 883-891
1977
ISSN/ISBN: 0026-895X PMID: 895723 Document Number: 120864
Document emailed within 1 workday
Related Documents
Cass, C.E.; Dahlig, E.; Lau, E.Y.; Lynch, T.P.; Paterson, A.R. 1979: Fluctuations in nucleoside uptake and binding of the inhibitor of nucleoside transport, nitrobenzylthioinosine, during the replication cycle of Hela cells Cancer Research 39(4): 1245-1252Clanachan, A.S.; Hammond, J.R. 1983: Thermodynamic differences between the binding interaction of nitrobenzylthioinosine and dipyridamole with the nucleoside transport system of human erythrocytes Proceedings of the Western Pharmacology Society 26: 251-253
Jarvis, S.M. 1986: Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole Molecular Pharmacology 30(6): 659-665
Steven, F.S.; Johnson, J.; Eason, P. 1993: A protein inhibitor, extracted from Hela cells, which recognises a cell surface protease on preneoplastic cells obtained from cervical smears Anticancer Research 13(4): 1059-1061
Plagemann, P.G. 1976: Transport, phosphorylation, and toxicity of a tricyclic nucleoside in cultured Novikoff rat hepatoma cells and other cell lines and relase of its monophosphate by the cells Journal of the National Cancer Institute 57(6): 1283-1295
Nair, C.N. 1988: Proton gradient independent organic cation transport by Hela cells Journal of Pharmacology and Experimental Therapeutics 246(1): 121-124
Röttele, J.; Zimmermann, H.W. 1993: Transport and accumulation of lipophilic dye cations at the mitochondria of Hela cells in situ Cellular and Molecular Biology 39(7): 739-756
Boone, C.W.; Irving, D.N.; Rubinstein, S. 1971: Quantitative studies on the binding of antibody to the surface of Hela cells Journal of Immunology 106(4): 879-887
Young, J.D.; Jarvis, S.M.; Clanachan, A.S.; Henderson, J.F.; Paterson, A.R. 1986: Nitrobenzylthioinosine: an in vivo inhibitor of pig erythrocyte energy metabolism American Journal of Physiology 251(1 Pt 1): C90-C94
Tew, K.D.; Sudhakar, S.; Schein, P.S.; Smulson, M.E. 1978: Binding of chlorozotocin and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to chromatin and nucleosomal fractions of Hela cells Cancer Research 38(10): 3371-3378
Mironova, A.A.; Barykina, N.V.; Zatsepina, O.V. 2014: Cytological analysis of the reaction of the nucleolar RNA and RNA-binding proteins to oxidative stress in Hela cells Tsitologiia 56(7): 489-499
Williams, E.F. 1992: Cation regulation of guinea pig cardiac nitrobenzylthioinosine binding sites Research Communications in Chemical Pathology and Pharmacology 78(2): 181-192
Brown, T.C.; Corman, N.; Rudkin, B.B.; Jiricny, J. 1989: Different patterns of G/T and A/C mismatch repair in simian cells correspond to the specificity of a mismatch binding protein isolated from simian and Hela cells Annali Dell'istituto Superiore di Sanita 25(1): 149-153
Romig, H.; Fackelmayer, F.O.; Renz, A.; Ramsperger, U.; Richter, A. 1992: Characterization of SAF-A, a novel nuclear DNA binding protein from HeLa cells with high affinity for nuclear matrix/scaffold attachment DNA elements EMBO Journal 11(9): 3431-3440
Lin, L.; Sun, W.; Wang, L. 2015: Effects of mesenchymal stem cells on angiogenesis of cervical cancer Hela cancer cell line Hela in vivo Zhonghua Yi Xue Za Zhi 95(15): 1175-1178
Dagnino, L.; Paterson, A.R. 1990: Sodium-dependent and equilibrative nucleoside transport systems in L1210 mouse leukemia cells: effect of inhibitors of equilibrative systems on the content and retention of nucleosides Cancer Research 50(20): 6549-6553
Ripamonti, D.; Maggiolo, F. 2008: Rilpivirine, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infection Current Opinion in Investigational Drugs 9(8): 899-912
Li, J.Y.; Jahn, R.; Dahlström, A. 1995: Rab3a, a small GTP-binding protein, undergoes fast anterograde transport but not retrograde transport in neurons European Journal of Cell Biology 67(4): 297-307
Dieterich, D.T. 2003: Long-term complications of nucleoside reverse transcriptase inhibitor therapy Aids Reader 13(4): 176-184; 187
Malkovský, M.; Asherson, G.L.; Chandler, P.; Colizzi, V.; Watkins, M.C.; Zembala, M. 1983: Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells Journal of Immunology 130(2): 785-790